摘要
针对肠道病毒68型(EV-D68)建立一种新型快速、高效的中和试验方法,并初步评价其在EV-D68流行病学研究中的应用价值。以灭活EV-D68病毒免疫Balb/c小鼠,利用杂交瘤技术制备其单克隆抗体;筛选反应性好、特异性强的抗EV-D68单克隆抗体作为检测抗体,基于酶联免疫斑点检测技术(ELISPOT)建立EV-D68高效中和试验方法;进一步比较该方法与传统中和试验方法 Nt-CPE的一致性,并使用该方法对临床血清样本进行检测。共获得10株分泌抗EV-D68单克隆抗体的杂交瘤细胞株,选取一株性能最优的15C5进行生产纯化,鉴定其为IgG3亚型;以15C5为检测抗体,建立了快速检测EV-D68中和抗体的Nt-ELISPOT方法;与Nt-CPE方法比较,Nt-ELISPOT方法将检测时间由5~7d缩短至1d以内,并且两种方法检测结果一致性良好;应用所建立的Nt-ELISPOT方法对厦门地区146份人群血清样本进行检测,显示血清样本EV-D68中和抗体阳性率为98.6%(144/146),提示厦门地区可能存在过EV-D68的流行。本研究基于ELISPOT建立的新型EV-D68中和试验方法快速可靠,适合通量检测,可以应用于EV-D68中和抗体水平的血清学调查,为EV-D68感染的防控工作提供帮助。
We wished to establish a novel,rapid and efficient neutralization test for enterovirus D68(EVD68)and evaluate its application in seroepidemiological studies.Balb/c mice were immunized with inactivated EV-D68.Monoclonal antibodies against EV-D68 were prepared by the hybridoma method.Anti-EVD68 monoclonal antibodies with high affinity and specificity were selected as detection antibodies for the establishment of a rapid neutralization test for EV-D68 using the enzyme-linked immunospot(ELISPOT)assay.Also,the consistency between the established method and conventional one,neutralization test based on the inhibition of cytopathic effects(Nt-CPE),was investigated.Finally,the established method was evaluated with clinical serum samples.Ten hybridoma cell lines secreting monoclonal antibodies against EVD68 were obtained,and the best of them,15C5,was selected for the production and characterization of monoclonal antibodies.Results showed that 15C5 was an immunoglobulin(Ig)G3subclass.A rapid method for the detection of neutralizing antibodies against EV-D68,Nt-ELISPOT,was established using 15C5 as the detection antibody.Nt-ELISPOT could shorten the detection time substantially from 5-7days in conventional Nt-CPE to〈 1day,and there was good consistency between the two methods.The established Nt-ELISPOT was applied to 146 clinical serum samples from Xiamen,China,and the positive detection rate was 98.6%(144/146),suggesting that EV-D68 infection might be prevalent in Xiamen.The established novel neutralization test for EV-D68 based on ELISPOT was rapid and reliable.This method could be used to detect EV-D68 neutralizing antibodies in seroepidemiological studies,thereby providing support for the prevention and control of EV-D68 infection.
出处
《病毒学报》
CAS
CSCD
北大核心
2017年第5期661-667,共7页
Chinese Journal of Virology
基金
国家自然科学基金(项目号:31670933),题目:手足口病肠道病毒跨血清型广谱中和抗体的表位结构与作用机制研究
国家自然科学基金(项目号:81601762),题目:人补体调节蛋白CD59在水痘-带状疱疹病毒免疫逃逸中的作用研究
福建省自然科学基金(项目号:2015J05073),题目:柯萨奇病毒A16型(CA16)广谱中和表位的结构基础